Cargando…
The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic Review
The introduction of immune checkpoint inhibitors (ICI), as a novel treatment modality, has transformed the field of oncology with unprecedented successes. However, the efficacy of ICI for patients with glioblastoma or brain metastases (BMs) from any tumor type is under debate. Therefore, we systemat...
Autores principales: | Brahm, Cyrillo G., van Linde, Myra E., Enting, Roelien H., Schuur, Maaike, Otten, René H.J., Heymans, Martijn W., Verheul, Henk M.W., Walenkamp, Annemiek M.E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139638/ https://www.ncbi.nlm.nih.gov/pubmed/32143288 http://dx.doi.org/10.3390/cancers12030586 |
Ejemplares similares
-
Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis
por: van Linde, Myra E., et al.
Publicado: (2017) -
Data-driven prioritization and preclinical evaluation of therapeutic targets in glioblastoma
por: Brahm, Cyrillo G, et al.
Publicado: (2020) -
Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study
por: Brahm, Cyrillo G., et al.
Publicado: (2018) -
Subclassification of Newly Diagnosed Glioblastomas through an Immunohistochemical Approach
por: Conroy, Siobhan, et al.
Publicado: (2014) -
Tumor Drug Concentration and Phosphoproteomic Profiles After Two Weeks of Treatment With Sunitinib in Patients with Newly Diagnosed Glioblastoma
por: van Linde, Myra E., et al.
Publicado: (2022)